|
Dr. Wollowitz joined Medivation as vice president, chemistry and manufacturing, in December 2006. She has more than 20 years of experience in drug discovery and development. Previously, she served as president of Wollowitz Associates, a consulting business that assists small and emerging pharmaceutical companies in process scale-up, outsourcing, in-licensing and regulatory approvals. Prior to that, she held various senior positions at Cerus Corporation, including vice president of chemical technology and vice president of shared sciences, where she led the discovery and product development of novel compounds for inactivation of pathogens in blood products. Dr. Wollowitz previously worked at Dow Chemical Company and has invented several novel antivirals, one of which is sold commercially in Europe, as well as novel pesticides and polymer additives. Dr. Wollowitz received her B.A. in chemistry from the State University of New York at Binghamton and her Ph.D. in organic chemistry from the University of Wisconsin at Madison. | 